A cancer specialist from Houston has been chosen to take control of the U.S. Food and Drug Administration (FDA), which is reviewing its CBD policy. President Donald Trump on Friday picked Dr. Stephen Hahn of the MD Anderson Cancer Center to permanently lead the agency, pending congressional affirmation. The 59-year-old oncologist would replace Dr. Scott Gottlieb, […]

Cancer specialist nominated to lead FDA is a post from: Marijuana Business Daily: Financial, Legal & Cannabusiness news for cannabis entrepreneurs

Visits: 533